TRUCE-11: An open-label, single-arm, multicenter phase II study of tislelizumab combined with nab-paclitaxel for muscle-invasive urothelial bladder carcinoma.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Zhouliang Wu, Yunkai Qie, Chong Shen, Peng Li, Ning Kang, Kaixuan Du, Hailong Hu
Institution: Second Hospital of Tianjin Medical University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162494042
Cites:
Cited by:
Related to: